Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Ms. Karen N. PrangeIndependent Director | -3,00k | 85,95k | Vendita | 28,65 | 26,37k | -10,21% |
| 2026-05-15 | Dr. Vinayak DoraiswamyChief Scientific Officer | -5,00k | 140,65k | Vendita | 28,13 | 91,88k | -5,16% |
| 2026-03-12 | Dr. Vinayak DoraiswamyChief Scientific Officer | -5,00k | 149,15k | Vendita | 29,83 | 96,88k | -4,91% |
| 2026-03-10 | Mr. Robert S. WhiteIndependent Chairman of the Board | 10,00k | 149,90k | Derivative Exercise and Retained Stock | 14,99 | 122,17k | 8,91% |
| 2026-03-06 | Mr. Michael H. CarrelCEO, President & Director | -6,00k | 0,00 | Other Disposition | - | 796,06k | -0,75% |
| 2026-03-01 | Mr. Salvatore PriviteraChief Technical Officer | -13,13k | 410,35k | Sale to Issuer | 31,26 | 158,05k | -7,67% |
| 2026-03-01 | Mr. Michael H. CarrelCEO, President & Director | -72,78k | 2,28M | Sale to Issuer | 31,26 | 796,06k | -8,38% |
| 2026-03-01 | Mr. Douglas J. SeithCOO | -22,95k | 717,35k | Sale to Issuer | 31,26 | 229,34k | -9,10% |
| 2026-03-01 | Ms. Angela L. WirickCFO | -22,97k | 717,89k | Sale to Issuer | 31,26 | 204,89k | -10,08% |
| 2026-03-01 | Dr. Vinayak DoraiswamyChief Scientific Officer | -15,59k | 487,19k | Sale to Issuer | 31,26 | 101,88k | -13,27% |
| 2026-03-01 | Mr. Justin J. NozneskyChief Marketing & Strategy Officer | -15,59k | 487,22k | Sale to Issuer | 31,26 | 106,40k | -12,78% |
| 2026-03-01 | Mr. Karl S. DahlquistChief Legal Officer | -15,69k | 490,38k | Sale to Issuer | 31,26 | 96,05k | -14,04% |
| 2025-12-10 | Mr. Michael H. CarrelCEO, President & Director | -4,00k | 0,00 | Other Disposition | - | 698,94k | -0,57% |
| 2025-11-24 | Mr. Sven A. WehrweinIndependent Director | -10,00k | 177,08k | Derivative Exercise and Sale | 19,95 - 38,00 | 34,37k | - |
| 2025-11-26 | Mr. Justin J. NozneskyChief Marketing & Strategy Officer | -5,17k | 192,64k | Vendita | 37,29 | 78,80k | -6,15% |
| 2025-11-21 | Ms. Maggie S. YuenIndependent Director | -3,00k | 107,16k | Vendita | 35,72 | 11,37k | -20,88% |
| 2025-11-13 | Mr. Michael H. CarrelCEO, President & Director | -6,00k | 0,00 | Other Disposition | - | 702,94k | -0,85% |
| 2025-09-12 | Mr. Justin J. NozneskyChief Marketing & Strategy Officer | -3,00k | 108,90k | Vendita | 36,30 | 83,96k | -3,45% |
| 2025-08-22 | Mr. Sven A. WehrweinIndependent Director | -5,00k | 85,25k | Derivative Exercise and Sale | 19,95 - 37,00 | 34,37k | - |
| 2025-08-19 | Mr. Sven A. WehrweinIndependent Director | -5,00k | 80,25k | Derivative Exercise and Sale | 19,95 - 36,00 | 34,37k | - |
| 2025-08-08 | Mr. Michael H. CarrelCEO, President & Director | -10,00k | 0,00 | Other Disposition | - | 708,94k | -1,39% |
| 2025-08-06 | Ms. Regina E. GrovesIndependent Director | -2,45k | 90,28k | Vendita | 36,82 | 33,72k | -6,78% |
| 2025-08-05 | Dr. Vinayak DoraiswamyChief Scientific Officer | -2,50k | 91,45k | Vendita | 36,58 | 71,87k | -3,36% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
